Guest guest Posted March 10, 2010 Report Share Posted March 10, 2010 Research just published in the Journal of Clinical Oncology reports on a large randomized clinical trial of 423 patients in the Polish Adult Leukemia Group, PALG-CLL3 Study. Conclusion: 'Cladribine and fludarabine in combination with cyclophosphamide are equally effective and safe first-line regimens for progressive CLL. Both combinations have unsatisfactory activity in patients with 17p13 (TP53 gene) deletion.' Abstract http://jco.ascopubs.org/cgi/content/abstract/JCO.2009.25.9630v1 ~chris http://cllcanada.ca Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.